Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Rula Hajj-Ali, MD is a Staff Physician at the Center for Vasculitis Care and Research at Department of Rheumatic and Immunologic Diseases. Dr Hajj-Ali is an Associate Professor at the Cleveland Lerner College of Medicine of Case Western Reserve University and has a joint appointment with the Department of Cell Biology at the Lerner Research Institute. She has been on staff in that department at the Cleveland Clinic since 2002. She is board-certified in internal medicine and Rheumatology.
Dr. Hajj-Ali is a graduate of the American University of Beirut medical school in Lebanon. She performed her internal medicine training at the American University of Beirut, Strong Memorial Hospital in Rochester NY and the Cleveland Clinic, followed by fellowship in rheumatic and immunologic disease at the American University of Beirut and the Department of Rheumatic and Immunologic Diseases at the Cleveland Clinic.
Dr. Hajj-Ali has a particular interest in systemic inflammatory disease and vascular inflammatory disease including vasculitides, primary central nervous system(CNS) vasculitis and inflammatory eye disease . Her research interests include central nervous system vasculitis, giant cell arteritis, Behçet’s Disease and Granulomatosis with Polyangiitis ( Wegener Granulomatosis). Dr. Hajj-Ali directs the multidisciplinary CNS vasculitis Clinic which is highly qualified multidisciplinary clinic that evaluate and treat patients with suspected CNS vasculitis , a tremendously challenging disease.
Dr. Hajj-Ali holds the alpha omega alpha honor and was elected as “America’s Top Physicians “and received the Cleveland Society of Rheumatology Best Fellow award, and the Clinical Research Award from the American Heart Association. She has been awarded the “Teacher of the Year award “in recognition to her excellence and dedication to the education of the fellows, residents and medical students.
Dr. Hajj-Ali has presented her research findings at various national and international scientific meetings. Her work in CNS vasculitis has been published in leading professional and scientific journals. She is the author of multiple chapters in major books for the topic of CNS vasculitis
Dr. Hajj-Ali is a member of numerous societies including the American College of Rheumatology and American College of Physicians. She is currently a consultant for the Vasculitis Foundation. She has served on the planning committee for the American College of Rheumatology annual meeting. Dr. Hajj-ali has lectured nationally and internationally on the subjects of Vasculitis, CNS vasculitis and inflammatory eye diseases.
Direct the Multidisciplinary Central Nervous System Vasculitis Clinic
Vasculitis, uveitis, central nervous system vasculitis, systemic inflammatory diseases
Fellowship in Rheumatology at the American University of Beirut
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 6/15/2015, Dr. Hajj-Ali has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.